Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

Lawson scientist researches best time to perform cleft alveolar surgery

Release issued 12th May 2008

Lawson scientist researches best time to perform cleft alveolar surgery


London Scientist Researches the Best Time to Perform Cleft Alveolar Surgery
Findings change the way doctors perform surgery around the world

LONDON, ON - Dr. Damir Matic is influencing the way cleft palate surgeries are performed throughout North America and around the world.

Dr. Matic, a scientist at the Lawson Health Research Institute and a craniofacial/plastic surgeon at London Health Sciences Centre, has been conducting research to determine the optimal time to close the gum tissue of cleft palate patients.

>>download as pdf

Traditionally, this has been a controversial topic with various cleft centers around the world opting for early closure at about 3-6 months of age. However, Dr. Matic, using research complied over the past 20 years has shown that the best time to close the cleft at the alveolus (gum) in patients with either one or two sided clefts is at eight or nine years of age prior to canine tooth eruption. "We close the lip at three months of age, we close the palate at one year old, but we don’t touch the gum until they are eight or nine, a time that corresponds to when the adult teeth start to appear," Dr. Matic says.

The study represents a significant breakthrough in cleft research involving an unprecedented sample size of 136 children. Dr. Matic and his team were able to look at a large group of children who had the cleft repair performed early, and then compare the group to a large group of children who had the repair performed when they were older.

"Cleft is the most common facial anomaly and the second most common congenital anomaly among children," Dr. Matic adds. "Our research is clinically based in terms of looking at how we can make our repairs better in light of our current knowledge and past discoveries. Based on our data, the down-side of early closure is much worse than any potential benefits, and repairing the cleft prior to this time (7-9 years) will damage facial growth."

Part one and two of the study looked at bone production and facial growth in unilateral clefts and was presented in 2006 and 2007 to the American Cleft Palate Association (ACPA), the largest society dedicated to cleft research in the world. Dr. Matic's research won best paper in the Junior Investigator Competition out of hundreds of submissions from around the world.

Part three of the study looked at how the repair affects bone production and facial growth in patients with bilateral clefts. These findings were presented at the ACPA meeting in Philadelphia last month. At this meeting, Dr. Matic was involved in a panel discussion/debate regarding his research where he recommended the later closure. The overall majority of the participants voted with Dr. Matic, leading to a change in recommendation in the way cleft palates will be treated in hospitals around the world.

"This study really put London on the map compared to our American and European counterparts, so this represents a major success for our cleft team," says Dr. Matic.

Dr. Matic is also an assistant professor in the department of surgery at The University of Western Ontario.

About Lawson Health Research Institute
As the research institute of London Health Sciences Centre and St. Joseph's Health Care, London, and working in partnership with The University of Western Ontario, Lawson Health Research Institute is committed to furthering scientific knowledge to advance health care around the world.

For more information, please contact:
Julia Capaldi
Lawson Health Research Institute
519-646-6100 ext. 61098
Julia.capaldi@sjhc.london.on.ca
www.lhrionhealth.ca

Company details

If you want to find out more about the company visit LAWSON Business Development profile.

Latest LAWSON Business Development press releases

Partnering consultation free of charge
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us